Abstract
Background:
Lipoprotein(a) [Lp(a)] is considered an independent risk factor for cardiovascular disease. Its concentration is mainly determined by the kringle-IV repeat copy number variation (CNV) at the apolipoprotein(a) [apo(a)] locus.
Objective:
We aimed to investigate the immediate effect of weight reduction on plasma Lp(a) levels and its dependency on the apo(a) CNV in obese children.
Design:
We performed a prospective longitudinal intervention study of a low-fat hypocaloric diet conducted in a 3-week dietary camp for obese children. In all, 140 obese participants (54 boys and 86 girls) with a mean age of 12.5±1.6 years and a mean relative body mass index (BMI) before treatment of 165.6±24.7% were included. Body weight and plasma levels of Lp(a), lipids, apolipoproteins A–I and B, insulin, and C-reactive protein were determined before the onset and after the end of the intervention. In addition, the number of apo(a) kringle-IV repeats were determined using sodium dodecyl sulfate agarose gel electrophoresis.
Results:
The mean loss of body weight was 5.0±1.3 kg (−6.6%), resulting in a mean decrease of the relative BMI of 6.6%. Blood chemistry revealed significant changes in all parameters, especially in Lp(a), with a decrease from 24.4±30.6 to 17.9±22.6 mg per 100 ml or −19% (P<0.001). The decrease of Lp(a) levels was higher in the group with low compared with high molecular weight apo(a) phenotypes (−23.9 vs −16.6%).
Conclusions:
Weight reduction in obese children is associated with significant changes in Lp(a) levels, especially in subjects with high pre-treatment Lp(a) concentrations. This effect is markedly influenced by the molecular phenotype at the copy-number variable apo(a) locus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK . Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008; 16: 2323–2330 Epub July 24, 2008.
Tudor-Locke C, Kronenfeld JJ, Kim SS, Benin M, Kuby M . A geographical comparison of prevalence of overweight school-aged children: the National Survey of Children's Health 2003. Pediatrics 2007; 120: e1043–e1050.
Mattsson N, Ronnemaa T, Juonala M, Viikari JS, Raitakari OT . Childhood predictors of the metabolic syndrome in adulthood. The Cardiovascular Risk in Young Finns Study. Ann Med 2008; 40: 542–552.
Boney CM, Verma A, Tucker R, Vohr BR . Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290–e296.
Daniels SR, Jacobson MS, McCrindle BW, Eckel RH, Sanner BM . American heart association childhood obesity research summit report. Circulation 2009; 119: e489–e517.
Zwiauer KF . Prevention and treatment of overweight and obesity in children and adolescents. Eur J Pediatr 2000; 159: S56–S68.
Tay J, Brinkworth GD, Noakes M, Keogh J, Clifton PM . Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol 2008; 51: 59–67.
Lingenhel A, Eder C, Zwiauer K, Stangl H, Kronenberg F, Patsch W et al. Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet. Int J Obes Relat Metab Disord 2004; 28: 1509–1513.
Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999; 100: 1154–1160.
Kamstrup PR, Benn M, Tybaerg-Hansen A, Nordestgaard BG . Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008; 117: 176–184.
Bennet A, Di AE, Erqou S, Eiriksdottir G, Sigurdsson G, Woodward M et al. Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. Arch Intern Med 2008; 168: 598–608.
Kronenberg F, Steinmetz A, Kostner GM, Dieplinger H . Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci 1996; 33: 495–543.
Utermann G . Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol 1999; 10: 133–141.
Utermann G . Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol 1999; 10: 133–141.
Sönnichsen AC, Richter WO, Schwandt P . Reduction of lipoprotein (a) by weight loss. Int J Obes 1990; 14: 487–494.
Yamashita T, Sasahara T, Pomeroy SE, Collier G, Nestel PJ . Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 1998; 47: 1308–1314.
Corsetti JP, Sterry JA, Sparks JD, Sparks CE, Weintraub M . Effect of weight loss on serum lipoprotein(a) concentrations in an obese population. Clin Chem 1991; 37: 1191–1195.
Muls E, Kempen K, Vansant G, Cobbaert C, Saris W . The effects of weight loss and apolipoprotein E polymorphism on serum lipids, apolipoproteins A-I and B, and lipoprotein(a). Int J Obes Relat Metab Disord 1993; 17: 711–716.
Kiortsis DN, Tzotzas T, Giral P, Bruckert E, Beucler I, Valsamides S et al. Changes in lipoprotein(a) levels and hormonal correlations during a weight reduction program. Nutr Metab Cardiovasc Dis 2001; 11: 153–157.
Mackinnon LT, Hubinger LM . Effects of exercise on lipoprotein(a). Sports Med 1999; 28: 11–24.
Drowatzky KL, Durstine JL, Irwin ML, Moore CG, Davis PG, Hand GA et al. The association between physical activity, cardiorespiratory fitness, and lipoprotein(a) concentrations in a tri-ethnic sample of women: the Cross-Cultural Activity Participation Study. Vasc Med 2001; 6: 15–21.
Byrne DJ, Jagroop IA, Montgomery HE, Thomas M, Mikhailidis DP, Milton NG et al. Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. J Clin Pathol 2002; 55: 280–285.
Kostka T, Lacour JR, Berthouze SE, Bonnefoy M . Relationship of physical activity and fitness to lipid and lipoprotein (a) in elderly subjects. Med Sci Sports Exerc 1999; 31: 1183–1189.
Mackinnon LT, Hubinger L, Lepre F . Effects of physical activity and diet on lipoprotein(a). Med Sci Sports Exerc 1997; 29: 1429–1436.
Palaniappan L, Anthony MN, Mahesh C, Elliott M, Killeen A, Giacherio D et al. Cardiovascular risk factors in ethnic minority women aged < or =30 years. Am J Cardiol 2002; 89: 524–529.
Martin S, Elosua R, Covas MI, Pavesi M, Vila J, Marrugat J . Relationship of lipoprotein(a) levels to physical activity and family history of coronary heart disease. Am J Public Health 1999; 89: 383–385.
Gutin B, Cucuzzo N, Islam S, Smith C, Stachura ME . Physical training, lifestyle education, and coronary risk factors in obese girls. Med Sci Sports Exerc 1996; 28: 19–23.
Taimela S, Viikari JS, Porkka KV, Dahlen GH . Lipoprotein (a) levels in children and young adults: the influence of physical activity. The Cardiovascular Risk in Young Finns Study. Acta Paediatr 1994; 83: 1258–1263.
Mora S, Cook N, Buring JE, Ridker PM, Lee IM . Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007; 116: 2110–2118.
Poskitt EM . Defining childhood obesity: the relative body mass index (BMI). European Childhood Obesity group. Acta Paediatr 1995; 84: 961–963.
Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V . Adiposity indices in children. Am J Clin Nutr 1982; 36: 178–184.
Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H . Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318–1328.
Kronenberg F, Trenkwalder E, Kronenberg MF, Konig P, Utermann G, Dieplinger H . Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). Kidney Int 1998; 54: 1385–1389.
Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, Konig P et al. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: impact on lipid-lowering therapy? Kidney Int 2004; 66: 348–354.
Ostermann T, Willich SN, Ludtke R . Regression toward the mean--a detection method for unknown population mean based on Mee and Chua's algorithm. BMC Med Res Methodol 2008; 8: 52.
Giuseppe Cicero AF, Derosa G, D'angelo A, Bove M, Gaddi AV, Borghi C . Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. Blood Press 2009; 1–6.
Kraemer WJ, Vingren JL, Silvestre R, Spiering BA, Hatfield DL, Ho JY et al. Effect of adding exercise to a diet containing glucomannan. Metabolism 2007; 56: 1149–1158.
Skelton JA, DeMattia LG, Flores G . A pediatric weight management program for high-risk populations: a preliminary analysis. Obesity (Silver Spring) 2008; 16: 1698–1701.
Beckmann JS, Estivill X, Antonarakis SE . Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability. Nat Rev Genet 2007; 8: 639–646.
Boman L, Ericson M . Lipoprotein A levels after intestinal bypass operation for morbid obesity. Obes Surg 1997; 7: 125–127.
Maso F, Lac G, Robert A, Jouanel P . Lipids and theirs carriers in sportsmen: the lipoprotein particles. Eur J Appl Physiol 2002; 88: 128–133.
Acknowledgements
We appreciate the technical assistance of Nadja Baumgartner from the Division of Genetic Epidemiology, Innsbruck Medical University. The project was supported by the Medizinische Forschungsförderung Innsbruck (Grant 2007-402) and the Österreichische Nationalbank (Grant 13059) to A Brandstätter and by a grant from the Austrian GEN-AU-Programme ‘GOLD’ to F Kronenberg.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brandstätter, A., Lingenhel, A., Zwiauer, K. et al. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation. Int J Obes 33, 1136–1142 (2009). https://doi.org/10.1038/ijo.2009.144
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2009.144
Keywords
This article is cited by
-
Prevalence and status of Lipoprotein (a) among Lebanese school children
Scientific Reports (2020)
-
Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome
Molecular Biology Reports (2017)
-
Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes
Diabetologia (2017)
-
Genetic risk sum score comprised of common polygenic variation is associated with body mass index
Human Genetics (2011)